Cost Effectiveness of Bisoprolol in the Treatment of Chronic Congestive Heart Failure in Sweden
- 1 January 2001
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 19 (9) , 901-916
- https://doi.org/10.2165/00019053-200119090-00002
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Willingness to Pay for a Quality-adjusted Life YearMedical Decision Making, 2000
- Angiotensin Converting Enzyme (ACE) Inhibitors and Heart FailurePharmacoEconomics, 1999
- ??-Blockers in Heart FailureDrugs, 1999
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997
- Theoretical issues in cost-effectiveness analysisJournal of Health Economics, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- The Pharmacoeconomics of ACE Inhibitors in Chronic Heart FailurePharmacoEconomics, 1996
- Clinical and Economic Factors in the Treatment of Congestive Heart FailurePharmacoEconomics, 1995
- Effects of ACE Inhibitors on Heart Failure in The NetherlandsPharmacoEconomics, 1993